N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Not applicable ClinicalTrials.gov

Extracorporeal Shock Wave Therapy With or Without Kinesiotaping for Plantar Fasciitis

Sponsor: Ankara City Hospital Bilkent • ClinicalTrials.gov ID: NCT07864948

Registry updated: 2026-10-08
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

This study aims to evaluate and compare the short- and mid-term effects of Extracorporeal Shock Wave Therapy (ESWT) alone versus a combination of ESWT and Kinesio Taping (KT) on pain, foot functionality, and plantar fascia thickness in patients with plantar fasciitis. A total of 48 patients with chronic plantar fasciitis will be included in this prospective, randomized controlled trial and randomly allocated into two groups: the ESWT group and the ESWT + Kinesio Taping group. Primary outcome measures include pain severity assessed via the Visual Analog Scale (VAS) for morning and general pain, foot functionality evaluated using the Foot Function Index (FFI), and plantar fascia thickness measured via ultrasonography. Evaluations will be conducted at baseline, immediately post-treatment, and at the 3-month follow-up.

Interventions

  • Kinesio Taping (Other)
    Kinesiology tape applied twice (once a week for 2 weeks) with mechanical correction and tension
  • Extracorporeal Shock Wave Therapy (ESWT) (Device)
    Patients will receive 3 sessions of focused ESWT at 1-week intervals (1800 to 2000 impulses per session at 0.20-0.30 mJ/mm²

Eligibility criteria

Inclusion Criteria: Age between 18 and 65 years Chronic heel pain for at least 3 months Localized pain and tenderness on palpation at the medial aspect of the calcaneal tuberosity with the ankle in full dorsiflexion Pain intensity of 50 mm or greater on the Visual Analog Scale (VAS) during the first step in the morning Ultrasonographic findings typical of plantar fasciitis (proximal plantar fascia thickness greater than 4 mm with alterations in the fibrillar pattern) Willingness to participate in the study and provide written informed consent Exclusion Criteria: Presence of any skin lesions or integrity disruption in the heel region History of inflammatory or rheumatic arthritis History of fracture, trauma, or surgery in the heel region Presence of systemic infection or malignancy Presence of a cardiac pacemaker Local injection into the heel region within the last 6 months, or use of topical or oral non-steroidal anti-inflammatory drugs (NSAIDs) within the last 2 weeks Unwillingness to participate in the study

Conditions

Plantar Fasciitis

Locations

  • Ankara Bilkent City Hospital — Ankara, Çankaya, Turkey (Türkiye)
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record